Author

@AccionEAFI AccionEAFI

Named quality-compounder analyst reasoning through capital allocation and moats in real time

Posts and replies with fundamental, long-term commentary on

trader score
+0.82
hit rate
55%
mean α
+1.24%
signals 14d
9

Grade = how their written analysis reads (A best). Trader score = how their last-20 timestamped calls performed vs SPY.

Their picks, scored

Across their last 20 scored bets: 55% hit rate, +1.24% mean alpha, trader score +0.82. Their last-14d mentions, direction-adjusted, have moved +0.6% since posting (mean over 7 mentions with price data).

Recent signals9receipts included
date (PT)tickerauthorsentwhat they saidsince thenreceipt
2026-08-27NVDA@AccionEAFI+0.70Highlights Nvidia's low multiple relative to 100% growth and 70% guidance in an approving rhetorical take.-4.6%
2026-08-26NVDA@AccionEAFI+0.50Argues semiconductors and software can simultaneously benefit from the AI theme.+3.8%
2026-08-26CRM@AccionEAFI+0.50Argues semiconductors and software can simultaneously benefit from the AI theme.+24.5%
2026-08-19·@AccionEAFI·Expresses hope that new flows revive biotech interest, financing and expansion·
2026-08-19TMO@AccionEAFI+0.25Reports sector inflows tied to news and identifies two exposed life-science names+1.4%
2026-08-19DHR@AccionEAFI+0.25Reports sector inflows tied to news and identifies two exposed life-science names+2.2%
2026-08-19MRNA@AccionEAFI+0.70Calls the mRNA cancer result important for Moderna, Merck and supplier Rovi.-20.9%
2026-08-19MRK@AccionEAFI+0.55Calls the mRNA cancer result important for Moderna, Merck and supplier Rovi.-2.5%
2026-08-19ROVI@AccionEAFI+0.45Calls the mRNA cancer result important for Moderna, Merck and supplier Rovi.·

Grade is our human read-worthiness rating; trader score is a rolling 20-bet hit-rate/alpha composite — different things, often disagreeing. “Since then” is direction-unaware in the table; the summary line above adjusts for which way they leaned.